Skip to main content
Clinical Trials/NCT04268147
NCT04268147
Completed
N/A

APDM Instrumented Data Exchange for Ataxia (IDEA) Study

University of Chicago5 sites in 1 country128 target enrollmentJune 1, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Spinocerebellar Ataxia Type 1
Sponsor
University of Chicago
Enrollment
128
Locations
5
Primary Endpoint
iSARA
Status
Completed
Last Updated
last year

Overview

Brief Summary

This research study is testing body-worn sensors to measure movement during simple tests of coordination, in order to evaluate the progression and severity of ataxia.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
June 30, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • SCA 1, 2, 3, 6, and FA with mutations in the pathogenic range confirmed from genetic testing
  • SCA: aged 18-75 years
  • FA: aged 12-30, diagnosed between ages 5-25
  • community dwelling
  • physically/cognitively capable of consenting/assenting and complying with the protocol based on investigator's judgement
  • able to walk independently 10 yards without an assistive device
  • able to sit or stand unassisted for 30 seconds
  • no other neurological or musculoskeletal disorder that could affect mobility
  • no other history of head injury, vestibular function, stroke, or other disorders that could affect mobility
  • willing and able to participate in a 2-year study

Exclusion Criteria

  • dementia that limits subjects' ability to follow directions
  • pain that limits mobility
  • SCA: enrolled in a clinical drug trial

Outcomes

Primary Outcomes

iSARA

Time Frame: 2 years

measurements collected by wearable inertial sensors during instrumented Scale for the Assessment and Rating of Ataxia (iSARA)

Ataxia App on Watch/iPhone

Time Frame: 2 years

Bi-weekly assessments completed on Ataxia Application for Apple Watches and iPhones. Data collected includes active monitoring of speech, stance, coordination, gait and patient-reported symptoms.

Falls Questionnaire

Time Frame: 2 years

Automatic email sent out to subjects inquiring about any falls and near falls they have experienced during the past month

Functional Staging

Time Frame: 2 years

Clinician evaluates severity of ataxia symptoms.

mFARS

Time Frame: 2 years

modified Friedreich's Ataxia Rating Scale (mFARS) measurements evaluated by clinician compared to measure severity of Friedreich's ataxia through coordination, speech, stance, and gait

Daily Life (UChicago site ONLY)

Time Frame: 2 weeks

APDM SmartSox technology used to measure daily life activity(movement, falls, etc.) of all University of Chicago subjects

SARA

Time Frame: 2 years

Scale for the Assessment and Rating of Ataxia (SARA) measurements evaluated by clinician to measure severity of spinocerebellar ataxia through coordination, speech, stance, and gait

Patient-Reported Questionnaires of Health

Time Frame: 2 years

Activities, Balance, and Confidence (ABC) Questionnaire; EQ-5D-5L Health Questionnaire; Modified Fatigue Impact Scale (MFIS-5); Activities of Daily Living (ADLs)

Timed 25 Foot Walk

Time Frame: 2 years

Subjects walk for 25 feet, as quickly and safely as possible, while being timed

Study Sites (5)

Loading locations...

Similar Trials